Australia markets closed

Surgery Partners, Inc. (SGRY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.45-0.91 (-3.59%)
At close: 04:00PM EDT
24.45 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.34B
Enterprise value 5.50B
Trailing P/E N/A
Forward P/E 43.29
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.93
Price/book (mrq)2.02
Enterprise value/revenue 2.31
Enterprise value/EBITDA 12.00

Trading information

Stock price history

Beta (5Y monthly) 2.86
52-week change 3-35.47%
S&P500 52-week change 3-14.73%
52-week high 363.87
52-week low 323.33
50-day moving average 330.80
200-day moving average 341.72

Share statistics

Avg vol (3-month) 3479.9k
Avg vol (10-day) 3474.34k
Shares outstanding 589.94M
Implied shares outstanding 6N/A
Float 837.84M
% held by insiders 11.71%
% held by institutions 1104.15%
Shares short (14 Sept 2022) 45.21M
Short ratio (14 Sept 2022) 411.92
Short % of float (14 Sept 2022) 418.01%
Short % of shares outstanding (14 Sept 2022) 45.79%
Shares short (prior month 14 Aug 2022) 44.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin -1.23%
Operating margin (ttm)14.07%

Management effectiveness

Return on assets (ttm)3.52%
Return on equity (ttm)5.17%

Income statement

Revenue (ttm)2.38B
Revenue per share (ttm)27.81
Quarterly revenue growth (yoy)13.30%
Gross profit (ttm)491.4M
Net income avi to common (ttm)-29.2M
Diluted EPS (ttm)-0.47
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)227.4M
Total cash per share (mrq)2.58
Total debt (mrq)3.44B
Total debt/equity (mrq)144.27
Current ratio (mrq)1.51
Book value per share (mrq)13.09

Cash flow statement

Operating cash flow (ttm)156.5M
Levered free cash flow (ttm)38.05M